CD8A and Huntington disease: These results indicate that Pep3 activity, which according to literature [32] induces p53 function, alters the percentages of CD8+ Treg, CD8+ Teff and CD8+ activated Teff in type 1 diabetes PBMC as well as in HD PBMC but with different kinetics.